KKR’s agreement to acquire Integer Holdings joins the multibillion-dollar privatisation of Hologic and American Industrial Partners’ purchase of Avanos Medical. The transactions differ substantially, but together they show why specialised medtech manufacturers, platforms and established healthcare franchises remain attractive to private capital even when near-term growth is uneven.
Find out how Hologic’s patent victory against Siemens Healthineers could reshape breast cancer detection technology and medtech competition.
Hologic’s Breast Cancer Index is changing endocrine therapy decisions. The bigger test is adoption in real-world breast cancer care.
FDA-grade evidence is getting bigger and harder to collect. OM1’s Hologic study shows how AI may change medtech submissions.
Hologic’s latest breast imaging AI data suggests stronger detection of hard-to-find cancers. Read what it could mean for screening adoption.